Alimera Sciences, Inc.
NASDAQ Global MarketTotal Valuation
Alimera Sciences, Inc. carries a market capitalization of 301.29M, placing it among publicly traded companies globally. Its enterprise value stands at 330.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 301.29M |
| Enterprise Value | 330.57M |
Share Statistics
Alimera Sciences, Inc. currently has 52.39M shares outstanding.
| Shares Outstanding | 52.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.72, and the price-to-book ratio stands at -0.63.
| PE Ratio | N/A |
| PS Ratio | 2.72 |
| PB Ratio | -0.63 |
| P/TBV Ratio | -5.14 |
| P/FCF Ratio | -50.50 |
| P/OCF Ratio | -48.50 |
Enterprise Valuation
On an enterprise value basis, Alimera Sciences, Inc. trades at an EV/EBITDA multiple of 26.28 and an EV/FCF ratio of 39.70. The EV/Sales ratio of 3.32 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,661.17 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.32 |
| EV / EBITDA | 26.28 |
| EV / EBIT | 1,661.17 |
| EV / FCF | 39.70 |
Financial Position
Alimera Sciences, Inc. maintains a current ratio of 2.79, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 180.41, indicating elevated leverage, while an interest coverage ratio of 0.92 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.79 |
| Quick Ratio | 2.41 |
| Debt / Equity | 180.41 |
| Debt / EBITDA | 5.56 |
| Interest Coverage | 0.92 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -9.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.02 |
Taxes
| Income Tax | -15,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Alimera Sciences, Inc.'s stock has gained approximately 110.64639% over the past 52 weeks. The 50-day moving average sits at 5.56, while the 200-day moving average is 4.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 110.64639% |
| 50-Day Moving Average | 5.56 |
| 200-Day Moving Average | 4.17 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Alimera Sciences, Inc. generated 99.68M in revenue and converted that into -14.70M in net income, yielding earnings per share of -0.30. EBITDA reached 12.58M, while operating income came in at 199,000.00.
| Revenue | 99.68M |
| Gross Profit | 86.11M |
| Operating Income | 199,000.00 |
| Pretax Income | -14.71M |
| Net Income | -14.70M |
| EBITDA | 12.58M |
| EBIT | 199,000.00 |
| Earnings Per Share (EPS) | -0.30 |
Balance Sheet
Alimera Sciences, Inc. holds 10.83M in cash and equivalents against 69.98M in total debt, resulting in a net debt position of 58.90M. Total book value stands at -427.53M, with working capital of 35.57M providing operational flexibility.
| Cash & Cash Equivalents | 10.83M |
| Total Debt | 69.98M |
| Net Debt | 58.90M |
| Equity (Book Value) | -427.53M |
| Book Value Per Share | -8.76 |
| Working Capital | 35.57M |
Cash Flow
Alimera Sciences, Inc. produced -5.60M in operating cash flow over the past twelve months. After subtracting -221,000.00 in capital expenditures, free cash flow totaled -5.82M - equivalent to -0.12 per share.
| Operating Cash Flow | -5.60M |
| Capital Expenditures | -221,000.00 |
| Free Cash Flow | -5.82M |
| FCF Per Share | -0.12 |
Margins
Alimera Sciences, Inc. operates with a gross margin of 86.39, reflecting its pricing power and cost economics. The operating margin of 0.20 and net profit margin of -14.74 provide insight into operational efficiency.
| Gross Margin | 86.39 |
| Operating Margin | 0.20 |
| Pretax Margin | -14.76 |
| Profit Margin | -14.74 |
| EBITDA Margin | 12.62 |
Dividends & Yields
The company's payout ratio of 3.77 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 3.77 |
| Shareholder Yield | 0.73 |
| FCF Yield | -1.98 |
Stock Splits
Alimera Sciences, Inc.'s most recent stock split took place on November 15, 2019 with a 15:1 split ratio.
| Last Split Date | 11/15/2019 |
| Split Ratio | 15:1 |
Scores
Alimera Sciences, Inc. posts an Altman Z-Score of -6.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.30 |